Analogues of Grubbsꢀ Second Generation Metathesis Catalyst
FULL PAPERS
(0.090 mmol, 71%): mp 113–1188C (capillary). DSC: Ti/Te/
Tp/Tc/Tf 83.8/114.3/123.7/128.0/129.38C (endotherm), 129.4/
134.6/146.8/154.0/159.58C (exotherm). TGA: onset of first
and second mass loss regimes (Te), 127.7 (3.4%) and
171.38C. Anal. calcd. (%) for C52H45Cl2F39N2PRu (1641.8):
C 38.04, H 2.76, N 1.71; found: C 37.85, H 2.83, N 1.67.
1H NMR (400 MHz, CD2Cl2): d=18.91 (s, 1H, Ru=CH),
7.83 (d, J=7.6 Hz, 2H of Ph), 7.51 (t, J=7.7 Hz, 1H of Ph),
7.18 (t, J=7.8 Hz, 2H of Ph), 6.99 (s, 2H of 2Mes), 6.37 (s,
2H of 2Mes), 4.20–3.90 (4H, NCH2CH2N), 2.59 (s, 6H,
2CH3), 2.28 (s, 3H, CH3), 2.23 (s, 6H, 2CH3), 1.94 (s, 3H,
1H NMR (400 MHz, CD2Cl2): d=18.90 (s, 1H, Ru=CH),
7.83 (d, J=7.6 Hz, 2H of Ph), 7.49 (t, J=6.4 Hz, 1H of Ph),
7.17 (t, J=7.8 Hz, 2H of Ph), 6.98 (s, 2H of 2Mes), 6.36 (s,
2H of 2Mes), 4.12–3.90 (2 m, 4H, NCH2CH2N), 2.59 (s, 6H,
2CH3), 2.27 (s, 3H, CH3), 2.22 (s, 6H, 2CH3), 1.93 (s, 3H,
CH3), 1.90–1.50 (br m, 12H,
P
[CH2)2]; 31P{1H} NMR
C
1673
(17)
[P(CH2CH2Rf10)3 +H]+,
568
(32)
[MÀP(CH2CH2Rf10)3]+, 532 (55) [MÀP(CH2CH2Rf10)3ÀCl]+.
CH3), 1.90–1.60 [br m, 12H,
P
(CH2)2]; 13C{1H} NMR
A
(100 MHz, CD2Cl2, partial): d=217.8 [d, J=90.2 Hz,
RuC(N)2], 150.9 (d, J=1.6 Hz), 139.6, 139.3, 138.4, 137.1,
136.9, 134.3, 130.8, 130.6, 129.8, 129.5, 129.2, 128.8, 52.2 (d,
J=3.4 Hz), 51.8 (d, J=1.6 Hz), 25.4 (t, J=22.7 Hz), 20.9,
20.8, 20.2, 18.4, 12.3 (d, J=21.6 Hz); 31P{1H} NMR
(162 MHz, CD2Cl2): d=19.96 (s); 19F NMR (282 MHz,
CD2Cl2, partial): d=À81.64 (t, J=9.3, CF3). MS (FAB, 3-
NBA): m/z (%)=1640 (5) [MÀH]+, 1605 (2.5) [MÀCl]+,
1073 (2.5) [P(CH2CH2Rf6)3 +H]+.
A
G
Complex 3 (0.0790 g, 0.109 mmol),[14] P(CH2CH2CH2Rf8)3
(1d;[10] 0,1700 g, 0.120 mmol), and CF3C6H5 (3.0 mL) were
combined in a procedure analogous to that for 4a. An iden-
tical work-up gave 4d as a pink solid; yield: 0.1695 g
(0.086 mmol, 78%); mp 101–1038C (capillary). DSC: Ti/Te/
Tp/Tc/Tf 102.6/106.6/109.4/111.4/117.88C (endotherm), 153.6/
167.3/173.3/176.8/189.88C (exotherm). TGA: onset of first
and second mass loss regimes (Te), 142.8 (3.9%) and
188.88C. Anal. calcd. (%) for C61H51Cl2F51N2PRu (1983.9):
C 36.93, H 2.59, N 1.41; found: C 36.74, H 2.51, N 1.35.
1H NMR (400 MHz, CD2Cl2): d=18.88 (s, 1H, Ru=CH),
7.88 (d, J=7.8 Hz, 2H of Ph), 7.50 (t, J=7.4 Hz, 1H of Ph),
7.15 (t, J=7.8 Hz, 2H of Ph), 6.98 (s, 2H of 2Mes), 6.34 (s,
2H of 2Mes), 4.12–3.85 (2 m, J=40.9 Hz, 4H, NCH2CH2N),
2.61 (s, 6H, 2CH3), 2.29 (s, 3H, CH3), 2.22 (s, 6H, 2CH3),
1.93 (overlapping s, 3H, CH3), 1.99–1.80, 1.60–1.44 and
A
N
Complex 3 (0.1201 g, 0.165 mmol),[14] P(CH2CH2Rf8)3 (1b;[10]
0.1524 g, 0.142 mmol), and CF3C6H5 (4.0 mL) were com-
bined in a procedure analogous to that for 4a. An identical
workup gave 4b as a pink solid; yield: 0.2050 g (0.106 mmol,
64%); mp 113–1158C (capillary). DSC: Ti/Te/Tp/Tc/Tf, 96.6/
112.4/117.1/120.0/130.38C (endotherm), 159.5/175.7/178.8/
180.0/186.88C (exotherm). TGA: onset of first and second
mass loss regimes (Te), 154.8 (4.5%) and 198.28C. Anal.
calcd (%) for C58H45Cl2F51N2PRu (1941.9): C 35.87, H 2.34,
1.25–1.10 [overlapping m, m, and m, 6H, 6H, 6H, P(CH2)3];
G
13C{1H} NMR (100 MHz, CD2Cl2, partial): d=218.4 [d, J=
90.6 Hz, RuC(N)2], 150.9, 139.6, 139.3, 138.4, 137.0, 136.9,
134.2, 130.7, 130.6, 129.7, 129.5, 128.8, 66.0, 52.2 (d, J=
3.7 Hz), 51.7, 25.4 (t, J=22.9 Hz), 20.9, 20.8, 20.2, 18.4, 12.3
(d, J=23.3 Hz); 31P{1H} NMR (162 MHz, CD2Cl2): d=22.37;
19F NMR (282 MHz, CD2Cl2, partial): d=À81.64 (t, J=
9.9 Hz, CF3). MS (FAB, 3-NBA): m/z (%)=1982 (65)
[MÀH]+, 1947 (25) [MÀCl]+, 1415 (100) [P(CH2CH2Rf8)3 +
H]+, 568 (10) [MÀP(CH2CH2CH2Rf8)3]+, 532 (20)
[MÀP(CH2CH2CH2Rf8)3ÀCl]+.
1
N 1.44; found: C 35.31, H 2.38, N 1.31; H NMR (400 MHz,
CD2Cl2): d=18.90 (s, 1H, Ru=CH), 7.83 (d, J=7.7 Hz, 2H
of Ph), 7.50 (t, J=7.3 Hz, 1H of Ph), 7.18 (t, J=7.7 Hz, 2H
of Ph), 6.99 (s, 2H of 2Mes), 6.40 (s, 2H of 2Mes), 4.20–
4.90 (dm, J=36.6 Hz, 4H, NCH2CH2N), 2.59 (s, 6H, 2CH3),
2.27 (s, 3H, CH3), 2.23 (s, 6H, 2CH3), 1.93 (s, 3H, CH3),
1.90–1.60 [br m, 12H, P
(CH2)2]; 13C{1H} NMR (100 MHz,
T
CD2Cl2, partial): d=218.4 [d, J=90.5 Hz, RuC(N)2], 150.9,
139.6, 139.3, 138.4, 137.0, 136.9, 134.2, 130.7, 130.6, 129.7,
129.4, 128.7, 52.2 (d, J=3.7 Hz), 51.7 (d, J=2.8 Hz), 25.4
(t, J=22.9 Hz), 20.9, 20.8, 20.2, 18.4, 12.2 (d, J=21.1 Hz);
31P{1H} NMR (162 MHz, CD2Cl2): d=20.17 (s); 19F NMR
(282 MHz, CD2Cl2, partial): d=À81.74 (t, J=10.0 Hz, CF3);
MS (FAB, 2-nitrophenyl octyl ether): m/z (%)=1940 (90)
[MÀH]+, 1905 (40) [MÀCl]+, 1373 (100) [P(CH2CH2Rf8)3 +
Experiments in Figure 2
(A): A two-neck flask was charged with 5 (0.0381 g,
0.159 mmol) and tridecane (0.0248 g, 0.135 mmol), and
flushed with nitrogen. Freshly distilled CH2Cl2 was added
(3.1 mL, giving a 0.051M solution). The solution was stirred
and 4b (0.0075 g, 0.0039 mmol, 2.5 mol%) was added
against a stream of nitrogen. Samples were periodically re-
moved by syringe for GC analyses.[34]
H]+,
568
(75)
[MÀP(CH2CH2Rf8)3]+,
532
(85)
[MÀP(CH2CH2Rf8)3ÀCl]+.
(B): A two-neck flask was similarly charged with 5
(0.0574 g, 0.239 mmol) and tridecane (0.0481 g, 0.261 mmol),
and flushed with nitrogen. Freshly distilled CH2Cl2 (5.0 mL,
giving a 0.048M solution) and CF3C6F11 (2.5 mL) were
added. The biphasic mixture was stirred and 4b (0.0116 g,
0.00598 mmol, 2.5 mol%) was added against a stream of ni-
trogen.
(B’): A two-neck flask was similarly charged with 5
(0.0490 g, 0.204 mmol), tridecane (0.0590 g, 0.320 mmol; GC
standard), freshly distilled CH2Cl2 (4.0 mL, giving a 0.051M
solution), CF3C6F11 (2.0 mL), and 4b (0.0097 g, 0.0050 mmol,
2.5 mol%).
A
N
Complex 3 (0.0800 g, 0.110 mmol),[14] P(CH2CH2Rf10)3 (1c;[10]
0.1840 g, 0.110 mmol), and CF3C6H5 (3.0 mL) were com-
bined in a procedure analogous to that for 4a. An identical
work-up gave 4c as
a
(0.081 mmol, 73%); mp 111–1148C (capillary). DSC: Ti/Te/
Tp/Tc/Tf 98.8/114.6/116.8/118.6/126.28C (endotherm), 153.6/
167.3/173.3/176.8/189.88C (exotherm). TGA: onset of first
and second mass loss regimes (Te), 173.4 (2.9%) and
198.08C. Anal. calcd. (%) for C64H45Cl2F63N2PRu (2241.9):
C 34.29, H 2.02, N 1.25; found: C 34.31, H 2.00, N 1.21.
Adv. Synth. Catal. 2007, 349, 243 – 254
ꢁ 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
251